Ray Dalio Lantheus Holdings, Inc. Transaction History

Bridgewater Associates, LP

$23.8 Billion
Q3 2025

A detailed history of Ray Dalio (Bridgewater Associates, LP) transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Bridgewater Associates, LP holds 296,918 shares of LNTH stock, worth $15.7 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

296,918

Previous 397,852 25.37%

Holding current value

$15.7 Million

Previous $32.6 Million 53.24%

% of portfolio

0.06%

Previous 0.14%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$50.11 - $83.83 $5.06 Million - $8.46 Million	-100,934 Reduced 25.37%	296,918 $15.2 Million
Q2 2025 Aug 13, 2025	BUY	$73.86 - $108.74 $6.99 Million - $10.3 Million	94,700 Added 31.24%	397,852 $32.6 Million
Q1 2025 May 14, 2025	BUY	$78.23 - $110.01 $15.1 Million - $21.3 Million	193,474 Added 176.4%	303,152 $29.6 Million
Q4 2024 Feb 13, 2025	BUY	$76.22 - $116.71 $2.99 Million - $4.58 Million	39,216 Added 55.66%	109,678 $9.81 Million
Q3 2024 Nov 13, 2024	SELL	$77.7 - $123.62 $3 Million - $4.78 Million	-38,671 Reduced 35.43%	70,462 $7.73 Million
Q2 2024 Aug 14, 2024	BUY	$58.87 - $83.05 $1.93 Million - $2.72 Million	32,763 Added 42.9%	109,133 $8.76 Million
Q1 2024 May 14, 2024	BUY	$51.07 - $68.26 $239,977 - $320,753	4,699 Added 6.56%	76,370 $4.75 Million
Q4 2023 Feb 14, 2024	SELL	$55.6 - $77.89 $431,066 - $603,881	-7,753 Reduced 9.76%	71,671 $4.44 Million
Q3 2023 Nov 13, 2023	BUY	$60.27 - $90.75 $369,816 - $556,842	6,136 Added 8.37%	79,424 $5.52 Million
Q2 2023 Aug 11, 2023	SELL	$82.41 - $99.65 $680,129 - $822,411	-8,253 Reduced 10.12%	73,288 $6.15 Million
Q1 2023 May 12, 2023	BUY	$47.76 - $82.86 $90,744 - $157,434	1,900 Added 2.39%	81,541 $6.73 Million
Q4 2022 Feb 13, 2023	SELL	$48.76 - $77.67 $1.32 Million - $2.11 Million	-27,115 Reduced 25.4%	79,641 $4.06 Million
Q3 2022 Nov 10, 2022	BUY	$61.42 - $86.29 $4,422 - $6,212	72 Added 0.07%	106,756 $7.51 Million
Q2 2022 Aug 11, 2022	BUY	$55.54 - $72.65 $594,333 - $777,427	10,701 Added 11.15%	106,684 $7.04 Million
Q1 2022 May 13, 2022	BUY	$24.28 - $56.64 $552,418 - $1.29 Million	22,752 Added 31.07%	95,983 $5.31 Million
Q4 2021 Feb 14, 2022	BUY	$22.54 - $30.44 $170,965 - $230,887	7,585 Added 11.55%	73,231 $2.12 Million
Q3 2021 Nov 12, 2021	SELL	$24.23 - $28.59 $104,310 - $123,079	-4,305 Reduced 6.15%	65,646 $1.69 Million
Q2 2021 Aug 13, 2021	BUY	$19.51 - $27.64 $1.36 Million - $1.93 Million	69,951 New	69,951 $1.93 Million

Others Institutions Holding LNTH

# of Institutions

479

Shares Held

68.9M

Call Options Held

538K

Put Options Held

328K

View Full List

About Lantheus Holdings, Inc.

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $3.64B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

More about LNTH

Track Ray Dalio's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.

Account